Abstract
The bioprospecting of compounds from marine macroalgae represents a significant trend in the development of antifungal agents to combat the impacts caused by pathogenic and mycotoxin-producing fungi. Accordingly, this study seeks to organize this evidence for the period between 2015 and 2025, utilizing several databases: CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), Google Scholar, PubMed, ScienceDirect, and Web of Science. The selected articles were subsequently organized using Excel. Forty-six articles were included in the review, with the studies primarily focusing on the African (55.6%) and Asian (24.4%) continents. A total of 66 genera and 127 species of macroalgae were identified, with the genera Ulva (40%) and Sargassum (31%) appearing most frequently. Fifty-seven fungal species were also identified among those tested, with the most frequent genera being Candida (44.4%), Aspergillus (37.8%), and Fusarium (33.3%). Furthermore, the presence of terpenoid, fatty acids, tannins, steroids, polysaccharides, flavonoids, and other compounds were observed in the extracts obtained, while the techniques for isolating microorganisms and extracting their chemical composition were discussed. In summary, the findings highlight the biotechnological potential of marine macroalgae extracts as promising sources of antifungal compounds for pharmaceutical and agricultural applications.

This publication has 67 references indexed in Scilit: